Patients taking certain heart burn medications, H2 blockers and certain diabetes medications
Contraindications Given the limited safety data, conservative contraindications would include pregnancy or plans to become pregnant, breastfeeding, age under 18, severe liver or kidney disease, and any condition requiring medications with unknown interaction potential
Patients with severe hepatic or renal impairment may require special consideration, though specific dosing guidelines for these populations have not been established
Sleep and stress management Poor sleep disrupts hormones involved in fat metabolism, including growth hormone, cortisol, and insulin sensitivity
Where SLU-PP-332 Belongs in Metabolic Research Context SLU-PP-332 belongs in a different but nearby metabolic research lane because published literature describes it as an ERR signaling chemical probe rather than an NNMT inhibitor [18]